Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Ryan

Showing results (241-250 of 274) with videos related to

Pageof 28
Sort By:
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patientsChristopher G Willett, Yves Boucher, Dan G Duda, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Nature Medicine|January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
JCO Oncology Practice|July 13, 2022
Supportive Oncology Care at Home Intervention for Patients With Pancreatic CancerRyan D Nipp, Eva Gaufberg, Charu Vyas, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinomaTheodore S Hong, David P Ryan, Darrell R Borger, et al.
Annals of Surgery|February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal CarcinomatosisFelipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.
Journal of the National Cancer Institute|September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor GenotypeTheodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04Michael J O'Connell, Linda H Colangelo, Robert W Beart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Pageof 28

Showing results (241-250 of 274) with videos related to

Sort By:
Pageof 28
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patientsChristopher G Willett, Yves Boucher, Dan G Duda, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Nature Medicine|January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
JCO Oncology Practice|July 13, 2022
Supportive Oncology Care at Home Intervention for Patients With Pancreatic CancerRyan D Nipp, Eva Gaufberg, Charu Vyas, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinomaTheodore S Hong, David P Ryan, Darrell R Borger, et al.
Annals of Surgery|February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal CarcinomatosisFelipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.
Journal of the National Cancer Institute|September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor GenotypeTheodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04Michael J O'Connell, Linda H Colangelo, Robert W Beart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Pageof 28